Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2016.328 | Epigenetic markers of type 2 diabetes and diabetic complications |
Prof. MA Ronald 馬青雲 |
| 2015.316 | Maternal exposure to Perfluorooctane sulfonate (PFOS) and the risk of childhood obesity and metabolic abnormalities in the offspring- analysis of a longitudinal birth cohort |
Prof. MA Ronald 馬青雲 |
| 2013.432 | Identification of epigenetic markers in offspring exposed to maternal hyperglycaemia | Prof. MA Ronald |
| 2015.040 | Progression of glucose intolerance, cardiometabolic risk factors and subclinical atherosclerosis in Chinese women with Polycystic Ovary Syndrome | Prof. MA Ronald |
| 2013.447 | Developing a Metagenomic Next-Generation Sequencing Software Platform for Discovering Biomarkers with Application to Obesity and Type 2 Diabetes | Prof. MA Ronald |
| 2016.103 | Unraveling the link between maternal hyperglycaemia and childhood obesity: Genome-wide methylation analysis in a prospective cohort of untreated gestational diabetes |
Prof. MA Ronald 馬青雲 |
| 2015.473 | Identification of genetic loci for birthweight and cardiometabolic traits in childhood |
Prof. MA Ronald 馬青雲 |
| 2013.042 | Identification of clinical and genetic predictors of hyperglycaemia and impaired beta-cell function in Chinese children- an analysis using mother-offspring pairs | Prof. MA Ronald |
| 2013.304 | An integrated trans-omics approach to diabetic cardio-renal complications: from novel discoveries to personalized medicine Substudy 2: The Hong Kong Diabetes Biobank | Prof. MA Ronald |
| 2011.047 | Identification of genetic variants assocaited with atrial fibrillation and its effect in subjects with diabetes | Prof Ma Ronald |
| 2013.187 | An integrated trans-omics approach to diabetic cardio-renal complications: from novel discoveries to personalized medicine | Prof. MA Ronald |
| 2011.354 | Identification of epigenetic markers associated with maternal diabetes and obesity | Prof. MA Ronald |
| 2011.302 | Identificatin and large-scale replication of genetic predictors of diabetic kidney disease and diabetic retinopathy in the Chinese population | Prof Ma Ronald |
| 2011.118 | Genetic determinants of obesity and cardiometabolic traits in Chinese adolescents | Prof. Ma Ronald |
| 2008.518 | Progression of cardio-metabolic risk factors in Chinese women with Polycystic Ovary Syndrome | Prof Ma Ronald |
| 2013.251 | An integrated trans-omics approach to diabetic cardio-renal complications: from novel discoveries to personalized medicine - Substudy 1: Transcriptome analysis of diabetic kidney disease | Prof. MA Ronald |
| 2008.519 | The role of neurohormonal dysregulation in the transgenerational effects of maternal diabetes | Prof Ma Ronald |
| 2018.357 | Comprehensive evaluation and mechanism investigation of the PAX4 gene R192H variant on diabetes, diabetes-related traits and diabetic complications |
Prof. MA Ronald 馬青雲 |
| 2025.200 | Using data to transform diabetes care and patient lives: Substudy 1: Hong Kong Gestational Diabetes Register | Prof. MA Ronald |
| 2022.475 | Translating multi-omic discoveries to transform diabetes care and reduce diabetic complications Substudy 1: A randomized controlled trial to evaluate the clinical utility of communicating polygenic risk scores in diabetes | Prof. MA Ronald |
| 2023.118 | Identifying genetic determinants of drug response in Chinese patients with type 2 diabetes for precision therapeutics |
Prof. MA Ronald Ching Wan 馬青雲 |
| 2022.207 | The impact of early-life exposure to metabolic abnormalities on pubertal development - from epidemiological analyses to mechanisms |
Prof. MA Ronald Ching Wan 馬青雲 |
| 2021.559 | The use of NT-proBNP for stratifying risk of cardio-renal complications in Chinese patients with Type 2 diabetes |
Prof. MA Ronald Ching Wan 馬青雲 |
| 2021.444 | Improving pregnancy outcomes, mothers’ and children’s metabolic health through dietary intervention and lifestyle modification during pregnancy |
Prof. MA Ronald Ching Wan 馬青雲 |
| 2022.141 | Using data to transform diabetes care and patient lives |
Prof. MA Ronald Ching Wan 馬青雲 |
| 2021.441 | A non-blinded retrospective biomarker add-on study to FIGARO-DKD for Bioprofiling the pharMacodynamic response to finerenone in FIGARO-DKD subjects (FIGARO-BM) |
Dr. MA Ronald Ching Wan 馬青雲 |
| 2023.146 | Improving Diabetes Care for young patients |
Prof. MA Ronald Ching Wan 馬青雲 |
| 2018.458 | Translating multi-omic discoveries to transform diabetes care and reduce diabetic complications |
Prof. MA Ronald Ching Wan 馬青雲 |
| 2018.476 | The Fenofibrate And Microvascular Events in Type 1 diabetes Eye. A randomised trial to evaluate the efficacy on retinopathy and safety of fenofibrate in adults with type 1 diabetes; A multicentre double-blind placebo-controlled study in Australia and Internationally |
Dr. MA Ronald Ching Wan 馬青雲 |
| 2019.315 | A multicenter, multinational, prospective, interventional, single-arm, Phase IV study evaluating the clinical efficacy and safety of 26 weeks of treatment with insulin glargine 300 U/mL (Gla-300) in patients with Type 2 diabetes mellitus uncontrolled on basal insulin |
Prof. MA Ronald Ching Wan 馬青雲教授 |
| 2020.120 | Type 2 Diabetes Organopathy by Magnetic Resonance Imaging (T2DOM) |
Prof. MA Ronald Ching Wan 馬青雲 |
| 2019.152 | Archival Of Human Biological Samples Of Investigator-initiated Studies In CU-Med Biobank | Prof. MA Ronald Ching Wan |
| 2019.232 | Semaglutide cardiovascular outcomes trial in patients with type 2 diabetes (SOUL) |
Prof. MA Ronald Ching Wan 馬青雲 |
| 2020.287 | Effect and safety of semaglutide 2.4 mg once-weekly on weight management in subjects with overweight or obesity |
Dr. MA Ronald Ching Wan 馬青雲 |
| 2019.138 | Establishing the basis for Precision Medicine for Hyperglycaemia in Pregnancy-the Stratification of Hyperglycaemia in Pregnancy (SHIP) Study |
Prof. MA Ronald Ching Wan 馬青雲 |
| 2015.547 | A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone on the reduction of cardiovascular morbidity and mortality in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease in addition to standard of care |
Prof. MA Ronald Ching Wan 馬青雲 |
| 2016.442 | RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS CARDIOVASCULAR OUTCOMES FOLLOWING TREATMENT WITH ERTUGLIFLOZIN (MK-8835/PF-04971729) IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED VASCULAR DISEASE, THE VERTIS CV STUDY |
Prof. MA Ronald Ching Wan 馬青雲 |
| 2014.645 | The effect of maternal vitamin D at pregnancy on adverse pregnancy outcome and children offspring’s cardio-metabolic risk in early childhood | Prof. MA Ronald Ching Wan |
| 2015.165 | The impact of Gestational Diabetes Mellitus on mother and their children’s cardio-metabolic risks - a 22-year follow up study | Prof. MA Ronald Ching Wan |
| 2013.500 | Gestational age specific thyroid function reference range in Hong Kong | Prof. MA Ronald Ching Wan |
| 2017.268 | A randomized clinical trial using a postnatal lifestyle modification program to improve diet, adiposity and metabolic outcome in mothers with gestational diabetes and their offspring | Prof. MA Ronald Ching Wan |
| 2014.424 | DECLARE Dapagliflozin Effect on CardiovascuLAR Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes | Prof. MA Ronald Ching Wan |
| 2015.641 | The impact of gestational diabetes mellitus and vitamin D deficiency during pregnancy on children’s cardiometabolic risk and methylation | Prof. MA Ronald Ching Wan |
| 2017.291 | Validation of a novel assay for measurements of biologically active Angiotensin peptides(AngP) by Liquid chromatography Mass Spectrometry(LCMS)for the screening and diagnosis of Conn’s syndrome in hypertensive patients |
Prof. MA Ronald Ching Wan 馬青雲 |
| 2011.407 | The cardiometabolic risk amongst women with a prior history of hypertensive disorder | Prof. MA Ronald Ching Wan |
| 2012.325 | Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Follow-up Study | Prof. MA Ronald Ching Wan |
| 2002.119 | Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study and Ancillary Studies | Prof. MA Ronald Ching Wan |
| 2012.544 | Arterial stiffness indices in mothers of Hyperglycaemia and Adverse Pregnancy outcome (HAPO) study and their children offspring – a HAPO follow-up study | Prof. MA Ronald Ching Wan |
| 2008.520 | The effect of maternal hyperglycaemia during pregnancy on mother's future cardiometabolic risk - a follow up on the HAPO study | Prof. MA Ronald Ching Wan |
| 2023.608 | Hong Kong Precision Medicine in Diabetes Initiative | Prof. MA Ronald Ching Wan |
Page 178 of 289.

